Nomura Holdings
HRMY icon

Nomura Holdings’s Harmony Biosciences HRMY Stock Holding History

Nomura Holdings’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.2M Sell
417,932
-103,015
-20% -$3.25M 0.02% 433
2026
Q1 		$14.6M Buy
520,947
+10,923
+2% +$358K 0.04% 332
2025
Q4 		$19.1M Buy
510,024
+72,861
+17% +$2.4M 0.03% 329
2025
Q3 		$12M Buy
437,163
+14,244
+3% +$491K 0.02% 466
2025
Q2 		$13.4M Buy
422,919
+335,237
+382% +$10.8M 0.03% 333
2025
Q1 		$2.91M Buy
87,682
+35,075
+67% +$1.26M 0.01% 910
2024
Q4 		$1.81M Buy
52,607
+34,308
+187% +$1.18M ﹤0.01% 1176
2024
Q3 		$732K Sell
18,299
-51,905
-74% -$1.82M ﹤0.01% 1187
2024
Q2 		$2.12M Sell
70,204
-1,776
-2% -$53.4K ﹤0.01% 924
2024
Q1 		$2.42M Buy
+71,980
New +$2.31M 0.01% 851

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nomura Holdings's HRMY Position: Q2 2026 in Review

Nomura Holdings reduced its Harmony Biosciences (HRMY) stake by 20% in Q2 2026, selling an estimated $3.25M and leaving 417,932 shares worth $15.2M. The position accounts for 0.02% of the portfolio, ranked #433.

Nomura Holdings first reported a position in HRMY in Q1 2024 and has held it in 10 quarters since. The position peaked at $19.1M in Q4 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Nomura Holdings held 417,932 shares of Harmony Biosciences worth $15.2M as of Q2 2026.
  • Nomura Holdings sold 103,015 Harmony Biosciences shares in Q2 2026, an estimated $3.25M.
  • Harmony Biosciences made up 0.02% of Nomura Holdings's portfolio in Q2 2026, its #433 holding.
  • Nomura Holdings first reported a position in Harmony Biosciences in Q1 2024 and has held it in 10 quarters since.
  • Nomura Holdings's Harmony Biosciences position peaked at $19.1M in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.